2018 is here. After training on VCT for over 6 months now the time has come. The system that most subjects fear more than an STD it might as well be called VD is coming to a Cherry Hill near you! Miss B will no longer have to rat the double I'd scoundrels out as a combination of i.d/fingerprint will be used. Sorry the system does not detect crazies so you might have to tolerate CRV a ltitle bit longer. Not even pfiser is immune from this vermin!
I take this as an overture to Parexel from VCT. Another clue that the Goliath is closer to a dea! Baltimore and Glendale will seal the monopoly hold of the Republican owned verification system.
Surprising that these Republican aRe not for bigger brother over reach since they like to pretend they are for smaller government. Well from the current situation they don't mine as long as result in more money in their pockets.
They can step on our HIPAA rights but sensible gun control put their logic into the dark ages. Hypocrites I tell you.
Talk about the MANY FACES OF EVE! May God help us all. In God of Money they trust!
This study is broken up into 3 legs back to back. Is each leg and elimination period for the next? So it it more like maximum payout will be 9500. Does anyone know what the projection is for how many will make it to the end. A bonus of 2500 is a big chunk to lose.
I think the rules applies. They will be less tolerant. They may also look at it in context of other cardio risk factors reflected in lipid panels, ecgs, inflammation markers; and now diabetic risk vis a vis a1c is also considered a vascular health risk.
The IRBs, FDA and ethics board are probably atching their heads. Doctors if they practice ignoring someone health problem could put their research career at risk; do no harm. Time will tell To be noted however is that the Obama administration at its end and now the Trump administration has made it easier for pharma to do their research. They can now fulfill study requirements with smaller groups and less cohorts.
I think a more reasonable approach is for studies to have tier cut off for bp for age and gender the same way they have for other lab values and telemetry. Some centers already apply the age approach to bp. To be noted the change in hypertension definition affects more men than women. Only 19% of women are affected under 45. The data on the same group of men are more troubling.
Most lab rats focus on the systolic, top number when they are excluded but the diastolic new cut off of 80 and above just moved a good 50% into the failure category. This number is less responsive to all the tricks employed when vitals are taken. Even doctors will tell you medication is better at controlling systole than diastole. Diastole occurs when the heart is at rest between beats which is 2/3 of cardiac cycle. To change soing at rest is like asking a possum to play more dead. Diastole is more responsive over time to conditioning so it's inversely proportional to time spent in studies. May be we will have a new terminology in study Non Clinical Significant Hypertension which means for purpose of the study they will ignore values >130/80 and <140/85. Why 85 verses 90 because a 5 point movement in diastole is twice as significant as a 5 point move in systole. Not to bore you but for every 2 point move in the top number the bottom should move only one. So if the top number jumps to 10 above 130 then you should only tolerate 5 point increase in diastole since the heart has to sustain this 5 point jump in pressure 2/3 time longer than the increase pressure of 10 in its contracted state.
Big Pharma is trying to con more people like they did with cholesterol to make more money. Before cholesterol 200 and below was considered normal it was 250 and below. The new guidelines resulted in more statin scripts written with billions more for Big Pharma. If you ask your doctor what is your difference in mortality between numbers of 200 and 250 he will most likely throw a blank. Well shift just got serious. The new lower guideline for hypertension is 130/80.That means more Americans will be placed on hypertensive drugs. For subjects it probably mean that many will have to rethink income options. Just like statin studies boomed when nornal cholesterol was revised to 200 expect the same for bp meds. But for many participants they will not be eligible for these studies. Demand and will mean these studies will pay more however. abcnews.go.com/Health/103-million-americans-high-blood-pressure-guidelines/story?id=51121618
Last Edit: Nov 13, 2017 20:22:58 GMT -5 by respect
Gerald Williams of Virginia,a veteran, passed away on Friday October 27th. After failing for urine in blood recently several times he discovered he had bladder cancer! The lesson: when you get flagged by a clinic follow through with your doctor.
Pfiser's aggresive approach to screening failure makes so much sense now!
Last Edit: Nov 19, 2017 13:10:22 GMT -5 by respect
The staff has already been trained so when will it be rolled out? That is the million dollar question? Will it be the finger enhanced verisystem? Most likely yes since they are all things technology and it would contain the bottle neck at an already slow check in process!
I'm confused. What is Kerri connection to VCT? Any connection could be a conflict of interest as data elements across the platforms could breach confidentially and certainly pose the issue of HIPAA violations!